CSIMarket
 


Moderna Inc   (MRNA)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Cumulative Moderna Inc 's Leverage Ratio for Trailing Twelve Months Period

MRNA's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:

MRNA Leverage Ratio for Trailing Twelve Months Period

(Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
Y / Y Equity Growth 127.49 % 133.9 % - - -
Y / Y Total Liabilities Growth 1632.92 % 1977.12 % 46231.38 % 12910.55 % 10252.46 %
Leverage Ratio for Trailing Twelve Months Period 1.57 1.33 0.77 0.39 0.22
Total Ranking # 2259 # 2030 # 1378 # 687 # 361
Seq. Equity Growth 74.67 % 49.84 % -7.19 % -6.35 % 79.59 %
Seq. Total Liabilities Growth 6.62 % 85.59 % 151.69 % 247.97 % 27.8 %


Leverage Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Due to net new borrowings of 6.62%, Leverage Ratio for Trailing Twelve Months Period improved to 1.57, above Moderna Inc 's average Leverage Ratio for Trailing Twelve Months Period.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Biotechnology & Drugs industry 163 other companies have achieved lower Leverage Ratio for Trailing Twelve Months Period than Moderna Inc . While Leverage Ratio for Trailing Twelve Months Period total ranking has deteriorated compare to previous quarter from 2030 to 2259.

What is Leverage Ratio?
Who are MRNA's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 164
Sector # 645
S&P 500 # 2253


Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
2.18 1.04 0.22
(Jun 30 2019)   (Jun 30 2020)




Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Jun 30 2021, within Biotechnology & Drugs Industry Leverage Ratio for Trailing Twelve Months Period
Cytomx Therapeutics Inc   3.21 
Surgalign Holdings Inc   3.08 
Infinity Pharmaceuticals Inc   3.06 
Coherus Biosciences inc   2.75 
Novavax inc   2.49 
Avantor Inc   2.46 
Cellular Biomedicine Group Inc   2.42 
Navidea Biopharmaceuticals Inc   2.42 
Akoya Biosciences Inc   2.20 
Sunwin Stevia International Inc   2.12 
Gilead Sciences Inc   2.10 
Erytech Pharma S a   2.03 
Wave Life Sciences Ltd   1.97 
Reynolds Consumer Products Inc   1.95 
Health Discovery Corporation  1.90 
Cidara Therapeutics Inc   1.88 
Brooklyn Immunotherapeutics Inc   1.85 
Eargo Inc   1.77 
Outlook Therapeutics Inc   1.71 
Integrated Biopharma Inc  1.66 
Curis Inc   1.61 
Nanostring Technologies Inc   1.54 
Acorda Therapeutics inc   1.51 
Sqz Biotechnologies Company  1.49 
Recursion Pharmaceuticals Inc   1.37 
Moderna Inc   1.28 
Biogen Inc   1.26 
Champions Oncology Inc   1.25 
Adma Biologics Inc   1.24 
Vitality Biopharma Inc   1.15 


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

VRA's Profile

Stock Price

VRA's Financials

Business Description

Fundamentals

Charts & Quotes

VRA's News

Suppliers

VRA's Competitors

Customers & Markets

Economic Indicators

VRA's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071